Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

marketwatch.com - Organon Shares Rise on Report of Sun Pharma Bid
Organon Shares Rise on Report of Sun Pharma Bid
MarketWatch

Shares of Organon rose after The Economic Times reported that Sun Pharmaceutical Industries was set to proceed on a binding $12 billion bid for the healthcare company. The stock jumped 19% to $8.23 in premarket trading. Through Thursday's close, it…

bloomberg.com - Stock Movers: Lumentum, Sun Pharma, Porsche
Stock Movers: Lumentum, Sun Pharma, Porsche
Bloomberg

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street. Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for…

seekingalpha.com - Dulan Lokuwithana - Organon rises as Sun Pharma nears buyout deal (OGN:NYSE)
Organon rises as Sun Pharma nears buyout deal (OGN:NYSE)
Seeking Alpha

Organon (OGN) shares continued to climb on Friday, adding ~11% in the premarket after media reports from India indicated that Mumbai-based generic drugmaker Sun Pharmaceutical Industries had submitted a $12B binding offer for the U.S. company.

thehindu.com - The Hindu Bureau - Raichur-based pharma firm wins two State safety awards
Raichur-based pharma firm wins two State safety awards
The Hindu

Raichur-based Shilpa Pharma Lifesciences Ltd. won two awards at the Karnataka State Level Safety Awards presentation during the National Safety Day celebrations at the NIMHANS Convention Centre in Bengaluru on Thursday. The event was organised by…

thehindu.com - Pratik Kashiramka - In breakthrough, cheap aluminium may replace costly catalysts in pharma
In breakthrough, cheap aluminium may replace costly catalysts in pharma
The Hindu

For more than a century, aluminium has been chemistry's workhorse — useful, abundant, cheap, albeit limited in its abilities as a catalyst. New work reported in Nature may change that. Transition metals such as palladium, rhodium, and…

fool.com - Reuben Gregg Brewer - Could Buying This Dividend Pharma Stock Today Set You Up for Life?
Could Buying This Dividend Pharma Stock Today Set You Up for Life?
The Motley Fool

If you are a retiree looking to supplement your Social Security checks with income you derive from dividend stocks, you'll want to get to know Johnson & Johnson (JNJ 0.07%). It has a dividend record that no other healthcare company can match…

thehindubusinessline.com - Sun Pharma shares down 4 per cent on reports of overtures for US-based Organon
Sun Pharma shares down 4 per cent on reports of overtures for US-based Organon
BusinessLine

Sun Pharmaceutical Industries' shares closed down almost 4 percent at ₹1,654.70 on BSE, following reports that the drugmaker was close to sealing a deal for US-based Organon, in a $12 billion deal, its biggest transaction yet. Known to be…

marketbeat.com - Urogen Pharma (NASDAQ:URGN) Shares Gap Up - Time to Buy?
Urogen Pharma (NASDAQ:URGN) Shares Gap Up - Time to Buy?
MarketBeat

Urogen Pharma (NASDAQ:URGN - Get Free Report) shares gapped up prior to trading on Friday. The stock had previously closed at $20.53, but opened at $21.40. Urogen Pharma shares last traded at $20.9650, with a volume of 93,817 shares changing hands.

marketbeat.com - HC Wainwright Decreases Earnings Estimates for Innate Pharma
HC Wainwright Decreases Earnings Estimates for Innate Pharma
MarketBeat

Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA - Free Report) - Stock analysts at HC Wainwright decreased their FY2026 earnings per share (EPS) estimates for shares of Innate Pharma in a report released on Tuesday, April 7th. HC Wainwright analyst…

marketbeat.com - BridgeBio Pharma (NASDAQ:BBIO) Raised to 'Moderate Buy' at Royal Bank Of Canada
BridgeBio Pharma (NASDAQ:BBIO) Raised to 'Moderate Buy' at Royal Bank Of Canada
MarketBeat

BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) was upgraded by stock analysts at Royal Bank Of Canada to a 'moderate buy' rating in a note issued to investors on Wednesday, Zacks.com reports. BridgeBio's Volatile Week Puts Biotech Stocks Under a…

thehindubusinessline.com - D-Street rebounds: Sensex, Nifty up 1%, auto stocks roar, Sun Pharma, Infosys, TCS top losers
D-Street rebounds: Sensex, Nifty up 1%, auto stocks roar, Sun Pharma, Infosys, TCS top losers
BusinessLine

Domestic equity benchmarks continued to trade in positive territory during the mid-trading session on Friday, as investors drew comfort from a fragile ceasefire between the US and Iran, easing near-term geopolitical concerns. Asian markets were…

marketbeat.com - Jefferies Financial Group Initiates Coverage on Urogen Pharma (NASDAQ:URGN)
Jefferies Financial Group Initiates Coverage on Urogen Pharma (NASDAQ:URGN)
MarketBeat

Equities researchers at Jefferies Financial Group assumed coverage on shares of Urogen Pharma (NASDAQ:URGN - Get Free Report) in a note issued to investors on Friday. The firm set a 'buy' rating and a $40.00 price target on the stock. Jefferies…

marketbeat.com - Zealand Pharma A/S (OTCMKTS:ZLDPF) Sees Strong Trading Volume - Still a Buy?
Zealand Pharma A/S (OTCMKTS:ZLDPF) Sees Strong Trading Volume - Still a Buy?
MarketBeat

Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) shares saw unusually-high trading volume on Friday. Approximately 20,050 shares changed hands during mid-day trading, an increase of 358% from the previous session's volume of 4,378 shares.The…

marketbeat.com - Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Down - What's Next?
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Down - What's Next?
MarketBeat

Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report)'s stock price gapped down prior to trading on Friday. The stock had previously closed at $26.56, but opened at $24.81. Ascentage Pharma Group International…

rediff.com - Nandita Malik - Indian Stock Market Rebounds: Sensex Nifty Surge on Banking, Global Cues
Indian Stock Market Rebounds: Sensex Nifty Surge on Banking, Global Cues
Rediff.com

Indian benchmark indices Sensex and Nifty surged over 1 per cent, propelled by robust buying in banking and financial counters and a positive global market sentiment, as investors anticipate progress in US-Iran negotiations. The Sensex surged…

Receive a Daily briefing on Pharma Industry News

Get Started